SPECTRAL AI, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
SPECTRAL AI, INC. (MDAI) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$11.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$10.00K, a 158.82% decline year-over-year.
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $17.00K.
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$2.00K, a 300.00% decline year-over-year.
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $1.00K.
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $37.00K.
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$9.00K, a 175.00% decline from fiscal 2023.
- SPECTRAL AI, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $12.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.00K 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $37.00K 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $36.00K 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $49.00K 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | $17.00K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$9.00K 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $13.00K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$2.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | -$2.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $12.00K 10-K · filed 2025-03-31 | |||
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |